<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: AVEO Oncology en EUSA Pharma presenteren resultaten Fase 1 van lopend Fase 1/2 –onderzoek TiNivo naar tivozanib en nivolumab tegen niercelkanker	</title>
	<atom:link href="https://www.novumpr.nl/2017/11/06/aveo-oncology-en-eusa-pharma-presenteren-resultaten-fase-1-van-lopend-fase-12-onderzoek-tinivo-naar-tivozanib-en-nivolumab-tegen-niercelkanker/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.novumpr.nl/2017/11/06/aveo-oncology-en-eusa-pharma-presenteren-resultaten-fase-1-van-lopend-fase-12-onderzoek-tinivo-naar-tivozanib-en-nivolumab-tegen-niercelkanker/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=aveo-oncology-en-eusa-pharma-presenteren-resultaten-fase-1-van-lopend-fase-12-onderzoek-tinivo-naar-tivozanib-en-nivolumab-tegen-niercelkanker</link>
	<description>NovumPR press releases</description>
	<lastBuildDate>Mon, 06 Nov 2017 14:26:49 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.8.2</generator>
</channel>
</rss>
